Ashour, R., Rewisha, E., Rady, M. A., Elkhadry, S. W., Abdelhalim, H., & Atef, M. Effectiveness of sorafenib in treating intermediate-stage hepatocellular carcinoma patients refractory to transarterial chemoembolization. BMC.
Chicago Style (17th ed.) CitationAshour, Reham, Eman Rewisha, Mohamed AKL Rady, Sally Waheed Elkhadry, Heba Abdelhalim, and Mohamed Atef. Effectiveness of Sorafenib in Treating Intermediate-stage Hepatocellular Carcinoma Patients Refractory to Transarterial Chemoembolization. BMC.
MLA (9th ed.) CitationAshour, Reham, et al. Effectiveness of Sorafenib in Treating Intermediate-stage Hepatocellular Carcinoma Patients Refractory to Transarterial Chemoembolization. BMC.
Warning: These citations may not always be 100% accurate.